NORETHINDRONE AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norethindrone And Ethinyl Estradiol, and when can generic versions of Norethindrone And Ethinyl Estradiol launch?
Norethindrone And Ethinyl Estradiol is a drug marketed by Watson Labs, Watson Pharms Teva, Dr Reddys Labs Sa, Mylan Labs Ltd, Naari Pte Ltd, Watson Labs Teva, Xiromed, Teva Branded Pharm, Amneal Pharms, Barr, and Lupin Ltd. and is included in twenty-four NDAs.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE AND ETHINYL ESTRADIOL?
- What are the global sales for NORETHINDRONE AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for NORETHINDRONE AND ETHINYL ESTRADIOL?
Summary for NORETHINDRONE AND ETHINYL ESTRADIOL
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 24 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 41 |
Patent Applications: | 131 |
DailyMed Link: | NORETHINDRONE AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Early Phase 1 |
Celerion | Phase 1 |
Achillion, a wholly owned subsidiary of Alexion | Phase 1 |